AI radiomics predicts spatial glioma recurrence on preoperative MRI: a systematic review
Abstract
BACKGROUND: Adult-type diffuse gliomas are highly infiltrative primary brain tumors in which, after a combination of surgery and chemoradiation therapy, tumor recurrence is inevitable. Artificial Intelligence (AI) models have been found capable to predict local and distant tumor recurrence at baseline, with the potential to guide surgical margins and enable focal dose escalation in radiotherapy. This study systematically reviews the literature on the performance of AI models in predicting local or distant tumor recurrence in glioma patients using preoperative MRI data.
METHODS: A systematic literature search was conducted across PubMed, EMBASE, and the Cochrane Library. Studies evaluating AI-based models for spatial recurrence prediction in gliomas using preoperative MRI were included. Study quality and methodological rigor were assessed using the PROBAST + AI tool.
FINDINGS: Eight studies, comprising 1004 high grade glioma patients, were included. A variety of machine learning and deep learning model architectures (e.g., Random Forest classifiers, Support Vector Machines and custom Convolutional Neural Networks) were employed. Input data were a heterogeneous combination of conventional MRI (e.g., T1CE, FLAIR) and more advanced imaging modalities (e.g., diffusion-weighted imaging). Considerable variability was reported with regard to sensitivity and specificity rates (ranging between 40 %-97 % and 29 %-98 %, respectively) for predicting tumor recurrence. The odds ratios for…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Learning from First-Generation Qualitative Approaches in the IS Discipline: An Evolutionary View and Some Implications for Authors and Evaluators (PART 1/2)
- Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models
- Prosthesis: New Technological Opportunities and Innovative Biomedical Devices
- The history and future of neural modeling for cochlear implants
- Ryanodine receptors: waking up from refractoriness
- Novel Transgenic Rabbit Model Sheds Light on the Puzzling Role of Matrix Metalloproteinase-12 in Atherosclerosis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.